Researchers have measured the antibody levels and types in hospitalized coronavirus disease 2019 (COVID-19) patients with different disease severity. Their results suggest gut immune pathways could ...

To prove their COVID-19 vaccines worked, companies had to enroll more than 100,000 participants in monthslong clinical trials. Next time, Peter Gilbert wants such tests to require only a few hundred ...

The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States has stretched health care informatics beyond its limits. This is largely due to the increased ...

Recently, scientists at the Hutch and around the world celebrated an important milestone in the fight against COVID-19: the identification of antibodies as correlates of protection for COVID-19 ...

A look at antibodies in patients soon after they were infected with the virus that causes COVID-19 showed key differences between those whose cases remained mild and those who later developed severe ...

Eagerly anticipated new research pinpoints antibodies scientists can test for to see if a COVID-19 vaccine is effective. These "correlates of protection" could speed the development of new vaccines or ...

Antibodies after COVID-19 vaccination peaked higher for women and younger people than men and individuals over the age of 65, respectively, but levels dropped by half within six months for everyone in ...